Abstract: Disclosed are a method and device for winding a foil coil of a stereoscopic wound iron core transformer. The device includes a rotating assembly, a driving device and a plurality of loading assemblies; the rotating assembly is provided with a through hole matched with an iron core post, the rotating assembly is provided with a gear plate and a track ring around the through hole, and the gear plate and the track ring are fixedly connected by a fixing block; the loading assembly includes a cylinder and a tension device, and the cylinder is movably connected with the rotating assembly; and a driving end of the driving device is connected with the gear plate.

Abstract: A winding die is disclosed, including: a gear baffle, where a middle portion of the gear baffle is provided with a first opening for placing an iron core post, and the gear baffle is provided with a first surface; and a cylinder, where the cylinder is arranged on the first surface of the gear baffle and connected with the gear baffle. The middle portion of the gear baffle is provided with the first opening for placing the iron core post, the gear baffle is fixedly connected with the cylinder, an external device is connected with a gear, and the cylinder on the gear baffle is driven to rotate around the iron core post by pulling the gear, so that a foil or an insulating material on the cylinder can be wound on the iron core post, finally realizing a foil winding.

Abstract: A winding cylinder of a stereoscopic wound iron core transformer is disclosed, including an outer cylinder, an inner cylinder and a tension assembly. The outer cylinder is movably connected with the inner cylinder through a bearing assembly, and the outer cylinder rotatable around an axis of the inner cylinder. The tension assembly includes a screw, a spring and a connecting assembly. The connecting assembly includes a fixing portion, a friction portion and a transmission portion, the friction portion and the transmission portion are both arranged around the inner cylinder, and the transmission portion is fixedly connected with the outer cylinder. A side face of the inner cylinder is provided with a through hole, and the fixing portion penetrates through the through hole and is fixedly connected with the friction portion.

Abstract: Various compositions that include a hydrophobic compound and a polyamino acid conjugate are prepared. The compositions described herein are useful for a variety of drug, biomolecule, and imaging agent delivery applications.

Abstract: Various compositions that include a hydrophobic compound and a polyamino acid conjugate are prepared. The compositions described herein are useful for a variety of drug, biomolecule, and imaging agent delivery applications.

Abstract: Various compositions that include a hydrophobic compound and a polyamino acid conjugate are prepared. The compositions described herein are useful for a variety of drug, biomolecule, and imaging agent delivery applications.

Abstract: Various compositions that include a hydrophobic compound and a polyamino acid conjugate are prepared. The compositions described herein are useful for a variety of drug, biomolecule, and imaging agent delivery applications.

Abstract: Compositions and methods are disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially using a transepithelial carrier peptide. The transepithelial peptide contains sufficient amino, guanidine or amidino groups to stimulate transepithelial delivery. In some embodiments, the transepithelial carrier and the peptide with incretin hormone activity are embedded in a pressure sensitive adhesive layer of a plaster or patch.

Abstract: Compositions and methods are disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially using a transepithelial carrier peptide. The transepithelial peptide contains sufficient amino, guanidine or amidino groups to stimulate transepithelial delivery. In some embodiments, the transepithelial carrier and the peptide with incretin hormone activity are embedded in a pressure sensitive adhesive layer of a plaster or patch.